LCTX·53566P109·US·equity·Healthcare - Biotechnology-Activist
LCTX (LINEAGE CELL THERAPEUTICS IN) is held by 68 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($8.8M), FIFTH THIRD BANCORP ($7.3M), BlackRock, Inc. ($6.1M). Net institutional sentiment: Mixed.
See how LCTX's score breaks down across 4 SEC sources
Showing 1-20 of 72
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer